Zomedica Corp. (ZOMDF)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostics	2.80M	2.43M	1.38M	391.00K	125.00K
Diagnostics Growth	15.13%	76.69%	252.17%	212.80%	-
Therapeutics Devices	26.20M	24.85M	23.81M	18.54M	4.01M
Therapeutics Devices Growth	5.41%	4.38%	28.43%	362.55%	-
Development Services	3.03M	-	-	-	-
Total	32.03M	27.29M	25.19M	18.93M	4.13M
Total Growth	17.39%	8.33%	33.05%	358.02%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	26.46M	22.56M	-	-	-
United States Growth	17.31%	-	-	-	-
Foreign	5.57M	4.73M	-	-	-
Foreign Growth	17.76%	-	-	-	-
Total	32.03M	27.29M	-	-	-
Total Growth	17.39%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error